UNCOVERING A ROLE FOR TFE3 FUSION PARTNERS IN DRIVING TRANSLOCATION RENAL CELL CARCINOMA.

$120,020FY2021Defense Health AgencyDOD

Dana-Farber Cancer Institute, Inc.

Investigators